Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6639)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Weiss V, Dueber J, Wright JP, Cates J, Revetta F, Parikh AA, Merchant NB, Shi C. Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms. World J Gastrointest Oncol 2016; 8(8): 615-622 [PMID: 27574554 DOI: 10.4251/wjgo.v8.i8.615] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i8/615.htm |
| Number | Citing Articles |
| 1 |
Md. Hafiz Uddin, Md. Najeeb Al-Hallak, Philip A. Philip, Herbert Chen, Bassel El-Rayes, Asfar S. Azmi. Aberrant transcription factors in the cancers of the pancreas. Seminars in Cancer Biology 2022; 86: 28 doi: 10.1016/j.semcancer.2022.08.011
|
| 2 |
B. Zhou, X. Zhou, C. Zhan, M. Jin, S. Yan. FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial–mesenchymal transition via the PI3K/AKT and ERK pathways. Journal of Endocrinological Investigation 2022; 46(6): 1115 doi: 10.1007/s40618-022-01959-4
|
| 3 |
Lingaku Lee, Tetsuhide Ito, Robert T Jensen. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies. Expert Review of Anticancer Therapy 2019; 19(12): 1029 doi: 10.1080/14737140.2019.1693893
|
| 4 |
Xi-Feng Jin, Gerald Spöttl, Julian Maurer, Svenja Nölting, Christoph Josef Auernhammer. Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects. Cancers 2020; 12(2): 345 doi: 10.3390/cancers12020345
|
| 5 |
Zena Saleh, Matthew C. Moccia, Zachary Ladd, Upasana Joneja, Yahui Li, Francis Spitz, Young Ki Hong, Tao Gao. Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. International Journal of Molecular Sciences 2024; 25(2): 1331 doi: 10.3390/ijms25021331
|
| 6 |
Yina Jiang, Juan Xie, Bo Wang, Yudong Mu, Peijun Liu. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas. Human Pathology 2018; 81: 166 doi: 10.1016/j.humpath.2018.07.005
|
| 7 |
Maja Kebe Radulovic, Jernej Brecelj, Andrej Gruden, Margareta Strojan Flezar. Role of endoscopic ultrasound-guided fine needle aspiration biopsies in diagnosing pancreatic neoplasms in the paediatric population: experience from a tertiary center and review of the literature. Radiology and Oncology 2024; 58(1): 78 doi: 10.2478/raon-2024-0008
|
| 8 |
Rui He, Wunai Zhang, Shuo Chen, Yang Liu, Wenbin Yang, Junhui Li. Transcriptional Profiling Reveals the Regulatory Role of DNER in Promoting Pancreatic Neuroendocrine Neoplasms. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.587402
|
| 9 |
Chandra Maharjan, Po Ear, Catherine Tran, James Howe, Chandrikha Chandrasekharan, Dawn Quelle. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers 2021; 13(20): 5117 doi: 10.3390/cancers13205117
|
| 10 |
Pengchen Chen, Qingshui Wang, Jianwei Xie, Hang Fai Kwok. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors. Seminars in Cancer Biology 2019; 58: 80 doi: 10.1016/j.semcancer.2019.04.005
|
| 11 |
Kenichi HIRABAYASHI, Tsubasa SAIKA, Nobuaki KATO, Hitoshi ITOH, Naoya NAKAMURA. Current status of pancreatic juice/pancreatic duct brush cytology and endoscopic ultrasound-guided fine needle aspiration cytology/ biopsy. Suizo 2020; 35(4): 293 doi: 10.2958/suizo.35.293
|
| 12 |
Wenchang Guo, Ted Farzaneh, Whayoung Lee, Ali Nael, Xiaodong Li, Vishal S. Chandan. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm. Pathology - Research and Practice 2021; 223: 153462 doi: 10.1016/j.prp.2021.153462
|
| 13 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.885895
|
| 14 |
Peyman Dinarvand, Wei‐Lien Wang, Sinchita Roy‐Chowdhuri. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations. Cytopathology 2022; 33(2): 216 doi: 10.1111/cyt.13080
|
| 15 |
M. Adelita Vizcaino, Andrew L. Folpe, Henry Huffman, Ripul R. Panchal, G. Petur Nielsen, Benjamin R. Kipp, Rust Turakulov, Kenneth Aldape, Caterina Giannini. Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case. Virchows Archiv 2023; 483(6): 899 doi: 10.1007/s00428-023-03695-3
|
| 16 |
Krystallenia I Alexandraki, Gregory A Kaltsas, Niki Karavitaki, Ashley B Grossman. The Medical Therapy of Craniopharyngiomas: The Way Ahead. The Journal of Clinical Endocrinology & Metabolism 2019; 104(12): 5751 doi: 10.1210/jc.2019-01299
|
| 17 |
Bo Zhou, Jie Xiang, Ming Jin, Xiang Zheng, Guogang Li, Sheng Yan. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08062-6
|